Stratification by risk factors predicts survival on the active treatment arm in a randomized phase II study of interferon-gamma plus/minus interferon-alpha in advanced renal cell carcinoma (E6890)

By Dutcher Janice   Fine Jason   Krigel Robert   Murphy Barbara   Schaefer Paul   Ernstoff Marc   Loehrer Patrick  

Medical Oncology, Vol. 20, Iss. 3, 2003-09 ,pp. : 271-281

Humana Press, Inc

Access to resources Recommend Favorite

Phosphorylated Signal Transducer and Activator of Transcription 1 is a potential predictor of interferon response in patients with advanced renal cell carcinoma

By      

Molecular Medicine Reports, Vol. 9, Iss. 5, 2014-01 ,pp. : 1929-1934

Spandidos Publications

Access to resources Recommend Favorite

Pregnancy During Alpha-interferon Therapy in Patients with Advanced Hodgkin's Disease

By Ferrari V.D.   Jirillo A.   Lonardi F.   Pavanato G.   Bonciarelli G.  

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 2121-2122

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGET

By Negrier S.   Jäger E.   Porta C.   McDermott D.   Moore M.   Bellmunt J.   Anderson S.   Cihon F.   Lewis J.   Escudier B.   Bukowski R.  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 899-906

Humana Press, Inc

Access to resources Recommend Favorite

Uncommon gastrointestinal bleeding during targeted therapy for advanced renal cell carcinoma: A report of four cases

By Fujihara Shintaro   Mori Hirohito   Kobara Hideki   Nishiyama Noriko   Ayaki Maki   Ohata Ryo   Ueda Nobufumi   Sugimoto Mikio   Kakehi Yoshiyuki   Masaki Tsutomu  

Oncology Letters, Vol. 10, Iss. 5, 2015-11 ,pp. : 2895-2898

Spandidos Publications

Access to resources Recommend Favorite